Clinical Trials Logo

Ganglion Cysts clinical trials

View clinical trials related to Ganglion Cysts.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06371131 Recruiting - Clinical trials for Postoperative Nausea and Vomiting

Effect of Stellate Ganglion Block on Postoperative Nausea and Vomiting

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

Postoperative nausea and vomiting is one of the most common postoperative complications second only to postoperative pain. Studies have reported that without any antiemetic prevention treatment, the overall incidence of PONV in surgical operations is up to 20-30%, and the incidence of PONV in high-risk patients such as thyroid surgery is even up to 70-80%. PONV not only increased discomfort and prolonged hospital stay; Severe cases can lead to wound dehysis, acid-base imbalance, water and electrolyte metabolism disorders, seriously affect the prognosis of patients. Although various prevention and treatment measures have been adopted in clinical practice, it still cannot be completely eliminated. Therefore, postoperative nausea and vomiting of thyroid is still a concern in clinical anesthesia work, so it is urgent to explore more simple and effective measures to prevent thyroid PONV. SGB is the injection of local anesthetics into loose connective tissue containing stellate ganglion. It has a clear effect on postoperative analgesia of thyroid surgery, and can play a certain role in preventing thyroid PONV by reducing the application of perioperative opioids. Few studies have reported that the incidence of PONV can be significantly reduced after the application of SGB in patients with thyroid surgery, which provides a certain basis for the prevention of thyroid PONV. Therefore, this study aims to explore the effect of right stellate ganglion block on preventing postoperative nausea and vomiting of thyroid, and to explore the possible mechanism of action.

NCT ID: NCT06300658 Recruiting - Hemodialysis Clinical Trials

Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery

Start date: March 9, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the role of stellate ganglion blockade (SGB) for preserving arteriovenous fistula in hemodialysis patients undergoing major lower limb orthopedic surgery.

NCT ID: NCT06244056 Recruiting - Clinical trials for Stellate Ganglion Block

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Start date: February 5, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

NCT ID: NCT06241924 Recruiting - Parkinson Disease Clinical Trials

Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

BAG-OSMOV
Start date: February 5, 2024
Phase: N/A
Study type: Interventional

The expression of hypokinetic and hyperkinetic motor symptoms is accompanied by pathological synchronous oscillations of neuronal activity in this cortico-subcortical network with a wide frequency range. The purpose of this research is to study cortico-subcortical oscillations and their synchronization in two pathologies emblematic of hypokinetic (Parkinson's disease) and hyperkinetic (epilepsies) phenomena using a simple motor task and comparing different situations.

NCT ID: NCT06112392 Recruiting - Parkinson Disease Clinical Trials

Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease

Start date: July 28, 2023
Phase: N/A
Study type: Interventional

At present, there are no reports on the application of stellate ganglion block in the treatment of Parkinson's disease patients at home and abroad. Based on the preliminary clinical observation, this project intends to apply stellate ganglion block in the treatment of patients with intermediate and advanced Parkinson's disease through an open, randomized controlled small sample clinical study. To determine whether stellate ganglion block can effectively improve motor symptoms and non-motor symptoms in patients with primary advanced Parkinson's disease.

NCT ID: NCT06078605 Recruiting - Glaucoma Clinical Trials

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

Start date: September 16, 2022
Phase: N/A
Study type: Interventional

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients : Clinical Trial, Cross-over Design, Double-blind, Placebo-control, Randomized, Single-center Study

NCT ID: NCT06033456 Recruiting - Mastectomy Clinical Trials

Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome

Start date: October 7, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of the combination of Ultra Sound (US) guided radiofrequency stellate ganglion block (SGB) and radiofrequency Thoracic Paravertebral block (TPVB) comparing to US-guided SGB or TPVB alone on the post-mastectomy pain syndrome (PMPS).

NCT ID: NCT05970146 Recruiting - Clinical trials for Complex Regional Pain Syndromes

Cervical Epidural and Stellate Ganglion Block in Upper Limb Complex Regional Pain Syndrome

Start date: August 1, 2023
Phase: Phase 4
Study type: Interventional

Evaluate the efficacy of two regimens of management in relieving chronic refractory pain in patients with upper limb complex regional pain syndrome after orthopedic trauma

NCT ID: NCT05952011 Recruiting - Anesthesia Clinical Trials

Effect of Stellate Ganglion Block on Internal Mammary Artery Dynamics

Start date: August 8, 2023
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the diameter of Left internal mammary artery and its blood flow by using the pulsatility index before and after the left stellate ganglion block in patients undergoing coronary artery bypass grafting.

NCT ID: NCT05932485 Recruiting - Clinical trials for Stellate Ganglion Block

Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Post-operative new-onset atrial fibrillation (POAF) is one of the most common arrhythmias in adults after direct intracardiac surgery with extracorporeal circulation. The incidence of POAF in coronary artery bypass grafting (CABG) is approximately 30%. POAF can lead to an increased risk of complications such as stroke, heart failure, and acute kidney injury, which not only prolongs the patient's hospital stay, but also increases hospital costs and mortality. operation, extracorporeal circulation, and the patient's underlying conditions (such as age, gender, hypertension, and diabetes), which cause sympathetic activation, inflammatory response, and myocardial ischemia in the organism. The stellate ganglion block (SGB) regulates the sympathetic tone of the innervated nerves and thus the autonomic function of the body. SGB can effectively regulate the sympathetic-parasympathetic imbalance. Also, SGB may exert some anti-inflammatory effects. In this study, ultrasound-guided SGB was used in CABG patients to investigate its effect on the occurrence of POAF.